New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Deerland Enzymes launches digestive health supplement

Deerland Enzymes launches digestive health supplement
ThioZymeYD is formulated to support digestive tract function by promoting a normal population of yeast in the small intestine.

Deerland Enzymes, an international enzyme dietary supplement formulator and contract manufacturer, has announced the release of the company’s latest product, ThioZymeYD™. This dietary supplement is formulated to support optimal digestive tract function by promoting a normal population of yeast in the small intestine. Overgrowth of yeast in the digestive tract results in abdominal pain and bloating, intestinal gas and diarrhea or constipation.

The ThioZymeYD formula uses natural ingredients including peptides, essential oils, chelators, and enzymes designed to support normal yeast population in the gut, such as Candida species. Vice President of Technology at Deerland Enzymes, Dr. John Deaton, explains, “When Candida overgrowth occurs in the small intestine, it is difficult to correct. The yeast binds to the lining of the small intestine and mounts its own defense mechanism preventing the body from removing it, causing harm to the digestive tract. By disrupting that mechanism and establishing basal yeast levels in the small intestine, the body’s natural defense mechanisms can re-establish control of the normal micro flora population needed in order to have a healthy digestive tract.”

Because low amounts of yeast are normal in the gut and are beneficial, ThioZymeYD works to support normal yeast populations. “ThioZymeYD supports the growth of good bacteria and normal population of yeast,” says Deaton.

The launch of ThioZymeYD represents the third dietary supplement conceived from Deerland Enzymes’ alliance with healthcare technology company, Thione International. “We are excited about this latest release in the ThioZyme line of products,” says Scott Ravech, CEO of Deerland Enzymes. “With Dr. Theodore Hersh, former co-director of the Division of Digestive Diseases at Emory University School of Medicine and our own Dr. John Deaton working collaboratively on this technology, we are ensured a best in class, science backed solution to this digestive challenge.”

Deerland Enzymes Inc., based in Kennesaw, Ga., offers a broad spectrum of plant, animal, fungal and bacterial-sourced enzymes. All are non-GMO and kosher, where applicable. The company specializes in customized formulations, collaborating with customers to develop innovative and often proprietary solutions. Deerland Enzymes also performs specialty contract manufacturing services, including bulk single powders or blends, liquids, hard shell capsules, and tablets; as well as bottling and labeling.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.